Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil and Galantamine in Post-stroke Cognitive Impairment
NCT00227994Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Apr 2003
- Primary completion
- Jan 2005
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of galantamine, donepezil in cognitive impairment, cerebrovascular accident (CVA), sponsored by University of Pittsburgh. Started Apr 2003; status: completed.
02
Drugs
galantaminedonepezil
03
Conditions
cognitive impairmentcerebrovascular accident (CVA)
Beyond the preview
Go deeper on NCT00227994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227994.